Coeptis Therapeutics Holdings Inc
0.00 (0.00%)


Draw Mode:

Volume 0
Bid Price 1.31
Ask Price 1.52
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Coeptis Therapeutics Holdings Inc COEP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.40 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 1.03 - 8.7551
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.40 USD

Coeptis Therapeutics Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.16M 5.12M 1.51M $ 75.00k $ - -0.66 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 4.18M -

more financials information »

Coeptis Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No COEP Message Board. Create One! See More Posts on COEP Message Board See More Message Board Posts

Historical COEP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.43651.551.191.3779,803-0.0365-2.54%
1 Month1.481.82111.191.54115,545-0.08-5.41%
3 Months1.632.031.191.59109,556-0.23-14.11%
6 Months8.208.75511.031.8597,008-6.80-82.93%
1 Year8.208.75511.031.8597,008-6.80-82.93%
3 Years8.208.75511.031.8597,008-6.80-82.93%
5 Years8.208.75511.031.8597,008-6.80-82.93%

Coeptis Therapeutics Description

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio comprises multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.